| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/2006 | WO2006012365A2 Protease inhibitor |
| 02/02/2006 | WO2006012329A2 Health supplement |
| 02/02/2006 | WO2006011792A2 Antimicrobial peptides derived from cap18 |
| 02/02/2006 | WO2006011588A1 Medicinal composition containing diabetes remedy |
| 02/02/2006 | WO2006011007A1 Combination anticancer therapy and pharmaceutical compositions therefore |
| 02/02/2006 | WO2006010939A1 Composition for delivery of an active agent |
| 02/02/2006 | WO2006010619A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | WO2006010603A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 02/02/2006 | WO2006010493A1 Diagnostics and therapeutics for diseases associated with ethanolamine kinase 1 (ek11) |
| 02/02/2006 | WO2006010376A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | WO2006001023A3 Chimeric proteins and uses thereof |
| 02/02/2006 | WO2005123772A3 Anti-cancer therapy |
| 02/02/2006 | WO2005120222A3 Genetically modified non-human mammals and cells |
| 02/02/2006 | WO2005117989A9 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/02/2006 | WO2005115439A9 Cerberus/coco derivatives and uses thereof |
| 02/02/2006 | WO2005107782A3 Use of a modulator of gene expression in the treatment of cancer |
| 02/02/2006 | WO2005087920A3 Recombinant chondroitinase abc i and uses thereof |
| 02/02/2006 | WO2005087254A3 Pharmaceutical compositions comprising interferon-tau |
| 02/02/2006 | WO2005086674A8 Brhf1 as a cancer diagnostic marker |
| 02/02/2006 | WO2005085861A3 Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer |
| 02/02/2006 | WO2005082070A3 Compositions and methods for the systemic treatment of arthritis |
| 02/02/2006 | WO2005066207A8 Glucagon-like peptide-1 analogs with long duration of action |
| 02/02/2006 | WO2005051996A3 Protein from horn fly saliva that disrupts hemostasis |
| 02/02/2006 | WO2005051413A3 Disease associated genes |
| 02/02/2006 | WO2005035759A8 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/02/2006 | WO2005014775A3 Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a |
| 02/02/2006 | WO2005005626A8 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 02/02/2006 | WO2004058940A3 Sirna-mediated gene silencing |
| 02/02/2006 | WO2004012669A3 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 02/02/2006 | WO2003096967A3 Dna vaccines encoding heat shock proteins |
| 02/02/2006 | WO2002101071A3 Cd43:modulators of mast cell degranulation |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025577 Endothelial cell growth factor methods of isolation and expression |
| 02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 02/02/2006 | US20060025574 32 human secreted proteins |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025571 Morphogen-induced dendritic growth |
| 02/02/2006 | US20060025570 Megakaryocyte stimulating factors |
| 02/02/2006 | US20060025565 purified polypeptide and fusion protein for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; axonal regeneration, side effect reduction of scar tissue formation |
| 02/02/2006 | US20060025479 Agents with leukotriene B4-like antiviral (enveloped RNA) activities |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025397 Method of resistance of epilepsy by suppressing the function of alpha 1g protein |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025373 Modulation of glucocorticoid receptor expression |
| 02/02/2006 | US20060025372 Antisense modulation of PTP1B expression |
| 02/02/2006 | US20060025367 Adenovirus vectors encoding brain natriuretic peptide |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060025348 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 02/02/2006 | US20060025347 IAP binding compounds |
| 02/02/2006 | US20060025346 Permeability enhancer |
| 02/02/2006 | US20060025345 Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease |
| 02/02/2006 | US20060025344 Ghrelin receptor inverse agonists for regulation of feeding behaviors |
| 02/02/2006 | US20060025343 Angiogenically effective unit dose fo FGF and method of adminstering |
| 02/02/2006 | US20060025342 Administering parathyroid hormone-related protein intermittently at a dosage of at least 500 mu g/day for at least one month,to increase bone mass densityat a rate of at least 1% per month; treating osteoporosis |
| 02/02/2006 | US20060025341 Isolated polynucleotide encoding inhibin-related proteins for treating cancer of epithelial, testicular, ovarian, prostate; biodrug protein; activin binding activity; hormone inhibitor; muscle regeneration |
| 02/02/2006 | US20060025340 Cerberus/Coco derivatives and uses thereof |
| 02/02/2006 | US20060025339 Corticotropin releasing factor 2 receptor agonists |
| 02/02/2006 | US20060025338 Compositions and methods for treatment of lymphatic and venous vessel arterialization |
| 02/02/2006 | US20060025337 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
| 02/02/2006 | US20060025336 Pharmaceutical compositions comprising combinations of factor VII polypeptides and aprotinin polypeptides |
| 02/02/2006 | US20060025335 Netrin compositions and methods of using the same |
| 02/02/2006 | US20060025334 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 02/02/2006 | US20060025333 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 02/02/2006 | US20060025332 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2006 | US20060025331 Administering anti-Flt4 antibody or an anti-VEGF-C antibody that inhibits binding between Flt4 ligand protein and Flt4 expressed in cells to treat breast cancer characterized by endothelial cells that express Flt4 tyrosine kinase |
| 02/02/2006 | US20060025330 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 02/02/2006 | US20060025329 Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments |
| 02/02/2006 | US20060025328 Compositions suitable for controlled release of the hormone GnRH and its analogs |
| 02/02/2006 | US20060025327 Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent |
| 02/02/2006 | US20060025326 Method for treating carrier particles and its use |
| 02/02/2006 | US20060024825 Method of promoting expansion of stem cells |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024798 Gene knockout; gene overexpression; liposomes |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024790 Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA |
| 02/02/2006 | US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 02/02/2006 | US20060024783 BMP10 propeptides and related methods |
| 02/02/2006 | US20060024779 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 02/02/2006 | US20060024764 Proteins producing an altered immunogenic response and methods of making the same |
| 02/02/2006 | US20060024760 Human brain carboxypeptidase B |
| 02/02/2006 | US20060024759 Complex of a chaperone with beta-amyloid and methods employing this complex |
| 02/02/2006 | US20060024750 identification of the natural ligand for the orphan G-Protein Coupled Receptor; diagnosis of conditions involving dysregulated receptor activity |
| 02/02/2006 | US20060024728 GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same |
| 02/02/2006 | US20060024727 Antisense modulation of C-reactive protein expression |
| 02/02/2006 | US20060024704 Detection of markers in nascent proteins |
| 02/02/2006 | US20060024696 Nucleic acid and polypeptide sequences from Lawsonia intracellularis and methods of using |
| 02/02/2006 | US20060024683 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024667 Compositions and methods for Alzheimer's disease |
| 02/02/2006 | US20060024393 Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases |
| 02/02/2006 | US20060024391 Dietary nutritional suppliments for persons smoking tobacco products |
| 02/02/2006 | US20060024374 Pharmaceutical compositions suitable for the treatment of ophthalmic diseases |
| 02/02/2006 | US20060024373 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 02/02/2006 | US20060024371 Crosslinking a protein with derivative of a hydrophilic polymer with a functionality of at least three to form a non-liquid hydrogel and incorporating a therapeutic agent; the hydrogel degrades over time back to a liquid form |
| 02/02/2006 | US20060024355 animal feed additives comprising blends of biological organs, soy hulls and proenzymes, having stability in air and water |
| 02/02/2006 | US20060024347 Coating medical device with solution comprising a synthetic heparin-binding growth factor analog comprising at least one sequence of amino acid residues binding a heparin-binding growth factor receptor (HBGFR), a hydrophobic linker region and a heparin-binding region; coating heparin-containing compound |
| 02/02/2006 | US20060024346 Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds |
| 02/02/2006 | US20060024334 Immunotherapeutic methods and systems |